The biotechnology company has developed an innovative biological deodorant ingredient that is respectful with the skin and the ecosystem. This active ingredient has a wide range of applications for the odour reduction in body, axilla, feet, scalp, while respecting the microbiota.
Barcelona, 20 May 2020.- Vytrus Biotech, the company specialised in plant stem cell culture for the cosmetic sector, has just launched a new biological deodorant ingredient that efficiently reduces body odour, DEOBIOME NONI. It consists of the first deodorant treatment that allows the axilla to perspire while avoiding the bad odour generation, while respecting the skin microbiota and the ecosystem.
This cosmetic ingredient covers different applications within the cosmetic industry: underarm deodorants (roll-on, creams, gels), feet treatment deodorants (gels, serums, creams), scalp treatments and body care (deodorizing body lotions, body odour modulation).
The flourishing clean movement, consumers who search and choose products with more natural and sustainable ingredients, is among the new growing trends. In the field of fighting body odour, there is a need for alternatives to conventional products but respectful with an important physiological function as sweat production, as well as respectful with the skin microbiota.
The daily battle against body odour is still dominated by two classical strategies: deodorants that often eliminate bacteria by applying alcohol bases or bactericidal actives and cover malodour by using perfume; and traditional antiperspirants whose strategy is based on clogging the pores with derivates of aluminium salts, thereby depriving the bacteria in the axilla of malodour precursors. Therefore, Vytrus Biotech has broadened the scope of axillary care by designing a biological deodorant treatment that efficiently eliminates the bad odour. This strategy consists of an innovative combination that addresses the care of the skin through a prebiotic technology, and the microbiota re-balancing, thus challenging the fight against body odour.
Òscar Expósito, CEO, CSO and co-founder of Vytrus Biotech, says: “the launch of DEOBIOME is a great achievement for our company, and it also implies a great scientific advance for body odour treatment as our ingredient is the first biological deodorant of the market. Furthermore, it respects the skin microbiota thanks to the innovative mechanism of action of the active”.
Deobiome Noni, made from Morinda citrifolia plant stem cells, is presented to the market as an alternative to conventional products, respectful with the skin and the environment, being a solution against body odour. It represents a big scientific step forward in body odour treatment.
About Vytrus Biotech
Vytrus Biotech is a company specialised in the development, production and commercialization of high added value active ingredients based on plant stem cell culture technology for cosmetic and dermocosmetic industry. Positioning as a pioneer in the use of this technology for business purposes gives Vytrus Biotech a solid foundation on which to build a sustainable competitive advantage. Through this technology, it is possible to obtain natural, patentable and efficient products. Vytrus has a team of more than 20 employees in its headquarters in Terrassa (Barcelona, Spain) and is present in Europe, USA, LATAM and Asia, among others, through its international network of distributors.
Alejandro Guirado: firstname.lastname@example.org / +34 93 127 81 06